Earlier research indicated that the inhibition of PIKfyve can reduce the proliferation and migration of liver cancer cells, lymphoma cells, and fibroblasts [44,45,46], increasing the secretion of exosomes and inducing secretory autophagy [47]. Here, PIKFYVE is linked to lymphoma.